Esperion Therapeutics, Inc.

Healthcare

NASDAQ:ESPR · NASDAQ Global Market

Market Cap $659.07M Beta 1.07 P/E (TTM) -107.3

$3.15 -0.32%

+$0.00 today

52W Low $0.95High $4.18

Vol 17.00M · Avg 12.29M

EPS (TTM) -$0.03Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+202.88%

Period High

$4.08

Period Low

$0.98

Latest

$3.15

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Absci Corporation

NASDAQ:ABSI

$1.14B

Ventyx Biosciences, Inc.

VTYX

$1.00B

Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS

$991.47M

Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

$801.41M

Aquestive Therapeutics, Inc.

NASDAQ:AQST

$462.58M

REGENXBIO Inc.

NASDAQ:RGNX

$417.20M

Emergent BioSolutions Inc.

NYSE:EBS

$411.48M

Orthofix Medical Inc.

NASDAQ:OFIX

$373.16M

SNDL Inc.

NASDAQ:SNDL

$368.17M

SIGA Technologies, Inc.

NASDAQ:SIGA

$308.05M

What is the latest ESPR filing?

The latest filing shown is DEFA14A dated Jun 16, 2026.

How many recent filings does ESPR have?

Intrinsic Alpha currently shows 20 recent filings for ESPR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.